<code id='E5C8112E7B'></code><style id='E5C8112E7B'></style>
    • <acronym id='E5C8112E7B'></acronym>
      <center id='E5C8112E7B'><center id='E5C8112E7B'><tfoot id='E5C8112E7B'></tfoot></center><abbr id='E5C8112E7B'><dir id='E5C8112E7B'><tfoot id='E5C8112E7B'></tfoot><noframes id='E5C8112E7B'>

    • <optgroup id='E5C8112E7B'><strike id='E5C8112E7B'><sup id='E5C8112E7B'></sup></strike><code id='E5C8112E7B'></code></optgroup>
        1. <b id='E5C8112E7B'><label id='E5C8112E7B'><select id='E5C8112E7B'><dt id='E5C8112E7B'><span id='E5C8112E7B'></span></dt></select></label></b><u id='E5C8112E7B'></u>
          <i id='E5C8112E7B'><strike id='E5C8112E7B'><tt id='E5C8112E7B'><pre id='E5C8112E7B'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:1
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
          Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

          Bayer'sU.S.president,SebastianGuth,emphasizedataninterviewattheSTATofficesinBostonthatthepharmacompa

          read more
          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more

          A public health expert passes on football's full body collisions for youths

          IftherewasonemomentthatledKathleenBachynskitoacareerstudyingthepublichealthsignificanceofsportsinjur